[Case of anesthesia for thoracoscopic thymectomy in a pediatric patient with myasthenia gravis: reversal of rocuronium-induced neuromuscular blockade with sugammadex]
- PMID: 22991811
[Case of anesthesia for thoracoscopic thymectomy in a pediatric patient with myasthenia gravis: reversal of rocuronium-induced neuromuscular blockade with sugammadex]
Abstract
Neuromuscular blocking drugs (NMBDs) can predispose patients with myasthenia gravis to postoperative paralysis and respiratory complications. We had a 12-year-old female patient undergoing thoracoscopic thymectomy. She had suffered from MGFA class IIa (mild systemic) myasthenia gravis for 4 months. Anesthesia was induced with 3 mg x kg(-1) of thiopental and 0.2 mg x kg(-1) of rocuronium, which was given incrementally to achieve 100% blockade. Anesthesia was maintained with oxygen, air, 2% sevoflurane and 0.2 microg x kg(-1) x min(-1) of remifentanil. 0.05 mg x kg(-1) of rocuronium was added when the TOF ratio recovered to 20%. Towards the end of the surgery, remifentanil was withdrawn and 4 microg x kg(-1) of fentanyl was given. Intercostal nerve block with 0.2% ropivacaine was performed to relieve postoperative pain. TOF ratio was 32% at the end, when we gave 2 mg x kg(-1) of sugammadex to get 100% reversal of neuromuscular blockade in 120 seconds. There was no residual paralysis and respiratory complications postoperatively.
Similar articles
-
[Reversal of rocuronium induced neuromuscular block with sugammadex in a patient with myasthenia gravis].Masui. 2013 Aug;62(8):972-4. Masui. 2013. PMID: 23984578 Japanese.
-
Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy.Acta Anaesthesiol Scand. 2013 Jul;57(6):745-8. doi: 10.1111/aas.12123. Epub 2013 May 16. Acta Anaesthesiol Scand. 2013. PMID: 23678983 Clinical Trial.
-
A new approach to anesthesia management in myasthenia gravis: reversal of neuromuscular blockade by sugammadex.Rev Esp Anestesiol Reanim. 2010 Mar;57(3):181-4. doi: 10.1016/s0034-9356(10)70194-8. Rev Esp Anestesiol Reanim. 2010. PMID: 20422852
-
Sugammadex: a cyclodextrin to reverse neuromuscular blockade in anaesthesia.Expert Opin Pharmacother. 2008 Jun;9(8):1375-86. doi: 10.1517/14656566.9.8.1375. Expert Opin Pharmacother. 2008. PMID: 18473711 Review.
-
A novel approach to reversal of neuromuscular blockade.Minerva Anestesiol. 2009 May;75(5):349-51. Minerva Anestesiol. 2009. PMID: 19412157 Review.
Cited by
-
Sugammadex for our little ones: a brief narrative review.Anesth Pain Med (Seoul). 2024 Oct;19(4):269-279. doi: 10.17085/apm.24092. Epub 2024 Oct 31. Anesth Pain Med (Seoul). 2024. PMID: 39512049 Free PMC article. Review.
-
Sugammadex: Applications in Pediatric Critical Care.J Pediatr Intensive Care. 2020 Sep;9(3):162-171. doi: 10.1055/s-0040-1705133. Epub 2020 Mar 6. J Pediatr Intensive Care. 2020. PMID: 32685243 Free PMC article. Review.
-
Sugammadex in the management of myasthenic patients undergoing surgery: beyond expectations.Ann Transl Med. 2019 Dec;7(Suppl 8):S307. doi: 10.21037/atm.2019.10.35. Ann Transl Med. 2019. PMID: 32016026 Free PMC article. No abstract available.
-
Neuromuscular Blocking Agents and Reversal Agents Among Hospitalized Children: A Cerner Database Study.Hosp Pharm. 2021 Oct;56(5):424-429. doi: 10.1177/0018578720918332. Epub 2020 May 5. Hosp Pharm. 2021. PMID: 34720141 Free PMC article.
-
Advantages and pitfalls of clinical application of sugammadex.Anesth Pain Med (Seoul). 2020 Jul 31;15(3):259-268. doi: 10.17085/apm.19099. Anesth Pain Med (Seoul). 2020. PMID: 33329823 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous